Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 01, 2022
Jan. 02, 2021
Dec. 28, 2019
Cash flows from operating activities:      
Net income $ 104,596 $ 14,218 $ 60,268
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 54,401 39,695 35,215
Goodwill impairment 0 31,871 0
Stock-based compensation expense 8,880 5,781 5,207
Amortization of debt issuance costs 498 1,107 717
Benefit for deferred income taxes (1,403) (3,631) (551)
Amortization of acquisition-related inventory step-up 558 1,874  
Forward contract (gains) losses, net (4,685) 5,458 (2,863)
Other, net 55 1,006 4,614
(Increase) decrease in, net of acquisition:      
Accounts receivable (32,352) 727 5,657
Inventories (52,549) 570 (1,450)
Income taxes receivable (688) 1,731 (2,459)
Other current assets 729 (1,856) (4,043)
Other assets 5,332 4,030 1,772
Increase (decrease) in, net of acquisition:      
Accounts payable 23,792 10,569 (10,750)
Accrued expenses and other liabilities 8,087 3,806 5,700
Income taxes payable 5,686 (5,127) 6,234
Other noncurrent liabilities (7,735) (3,273) (2,057)
Contingent consideration payments in excess of acquisition date fair value 0 0 (10,731)
Net cash provided by operating activities 113,202 108,556 90,480
Cash flows from investing activities:      
Acquisitions of businesses, net of cash acquired (61,106) (217,029)  
Capital expenditures (26,794) (14,580) (25,025)
Proceeds from dispositions of equipment 175 100 196
Cash settlement of forward contracts 2,356 (3,524) 2,478
Software development costs (2,499) (865)  
Amounts paid for net assets acquired (2,400)    
Net cash used in investing activities (90,268) (235,898) (22,351)
Cash flows from financing activities:      
Borrowings on revolving credit facilities 81,189 117,565 129,951
Repayment of borrowings on revolving credit facilities (86,823) (79,609) (176,750)
Borrowings on long-term non-revolving debt 12,026 119,727  
Repayment of borrowings on long-term non-revolving debt (16,244) (5,958) (5,465)
Proceeds from stock issued 1,822 1,344 1,650
Dividends to shareholders (11,610) (11,550) (11,525)
Debt issuance costs 0 (1,714)  
Payment of contingent consideration liability (328) (830) (8,016)
Other financing activities (2,628) (1,234) (1,588)
Net cash (used in) provided by financing activities (22,596) 137,741 (71,743)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 2,986 (7,304) 2,261
Net increase (decrease) in cash, cash equivalents and restricted cash 3,324 3,095 (1,353)
Cash, cash equivalents and restricted cash, beginning of period 25,257 22,162 23,515
Cash, cash equivalents and restricted cash, end of period 28,581 25,257 22,162
Cash paid:      
Income taxes 23,570 11,341 11,421
Interest 15,860 11,567 14,252
Supplemental disclosure of noncash transactions:      
Common stock issued to ESOP through accrued expenses and other liabilities 0 0 1,152
Unrealized (gain) loss on interest rate swap (5,952) 1,887 $ 3,482
Contingent consideration incurred in connection with acquisition 3,269 1,919  
Indemnified tax liability incurred in connection with acquisition 0 3,559  
Stock issued for acquisition 14,159    
Foreign currency remeasurement impact on euro denominated debt 5,857 $ 7,246  
Measurement period adjustments to goodwill $ 822